A neonate with a unique non-Down syndrome transient proliferative megakaryoblastic disease

Eline J M Bertrums, Arjan Buijs, Martine van Grotel, Natasja Dors, Jasmijn D E de Rooij, Valerie de Haas, Sanne Hopman, Marjolijn C J Jongmans, C M Zwaan, Marry M van den Heuvel-Eibrink

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Transient myeloproliferative disorder (TMD) is a leukemia type that occurs typically in newborns. In Down syndrome, TMD is referred to as transient abnormal myelopoiesis (TAM).(32) Recently, transientness has also been reported in acute myeloid leukemia patients with germline trisomy 21 mosaicism, and even in cases with somatic trisomy 21, with or without GATA1 mutations. TMD cases without trisomy 21 are rare, and recurrent genetic aberrations that aid in clinical decision-making are scarcely described. We describe here a TMD patient without trisomy 21 or GATA1 mutation in whom single-nucleotide polymorphism analysis of leukemic blasts revealed a novel combined submicroscopic deletion (5q31.1-5q31.3 and 8q23.2q24).

Original languageEnglish
Article numbere26230
JournalPediatric Blood & Cancer
Volume64
Issue number3
DOIs
Publication statusPublished - 1 Mar 2017

Keywords

  • Down syndrome
  • EXT1
  • GATA1
  • non-Down syndrome
  • transient abnormal myelopoiesis
  • transient leukemia
  • transient myeloproliferative disease
  • transient myeloproliferative disorder
  • trisomy 21

Fingerprint

Dive into the research topics of 'A neonate with a unique non-Down syndrome transient proliferative megakaryoblastic disease'. Together they form a unique fingerprint.

Cite this